Praxis Precision Medicines

Praxis Precision Medicines

  • Founded: 2015
  • Location: Boston, MA
  • Employee range: 50 - 200
  • Clinical stage: Clin2
  • Therapy area: Parkinson's
  • Drug types: NEU, PED
  • Lead product: Ulixacaltamide
  • Product link:
  • Funding: $59M stock Jun 2023; $219M IPO Oct 2020; $110M C1 Jul 2020; $100M total May 2020
  • Investors: Blackstone Life Sciences, Novo Holdings, Vida Ventures, Eventide

job board

Short description:

Genetic Neuroscience Treatments

Drug notes:

Also Clin2 essential tremor; PRAX-562 Clin2 epilepsy; PRAX-628 Clin1 focal epilepsy; PRAX-222 Clin1 epilepsy; 6 programs Clin0 CNS disorders

Long description:

Contact us to add description:


Praxis Precision Medicines
Senior Pharmacokinetic Scientist (55304)
Boston, MA|45 days ago
Praxis Precision Medicines
Corporate Counsel (55240)
Boston, MA|51 days ago
Praxis Precision Medicines
Director, Quality Operations, CMC (55193)
Boston, MA|53 days ago
Praxis Precision Medicines
Senior Manager, Regulatory Strategy (55101)
Boston, MA|55 days ago
Praxis Precision Medicines
Senior Medical Director, Clinical Development Epil...
Boston, MA|89 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy